Special Issue "Pain, Psychiatry and Addiction"

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".

Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 4518

Special Issue Editors

Dr. Angelo G. I. Maremmani
E-Mail Website
Co-Guest Editor
1. Department of Psychiatry, North-Western Tuscany Local Health Unit, Tuscany NHS, Versilia Zone, Viareggio, Italy
2. PISA-School of Experimental and Clinical Psychiatry, Pisa, Italy
Interests: clinical aspects and treatment of dual disorder patients; opioid use disorder; heroin use disorder; pain and addiction

Special Issue Information

Dear Colleagues,

Painful somatic symptoms are common in psychiatric patients, especially among depressed patients, and it is concerning when PSS are expressed in bipolar or in (sub)-threshold bipolar patients.

In many countries, the broad availability of prescription pain medications (PPMs) and prescription substitution medications (PSMs), coupled with public misconceptions about their safety and addictive potential, have contributed to the recent surge in the nonmedical use of prescription opioids (POs) and corresponding increases in treatment admissions for problems related to opioid misuse. Prescription opioid use disorder (POUD) is an established public health crisis in many countries, and current evidence indicates it is a growing problem in Europe. Many specialists play a role in these different kinds of painful manifestations, including pain, psychiatry, and addiction medicine specialists, especially in the diagnosis and management of POUD. Still, neither group can adequately address these patients’ needs alone. The purpose of this Special Issue of JCM was to bring together experts from pain, psychiatry, and addiction medicine to examine the positions of all three specialities in assessing and treating PSSs in psychiatric and/or in POUD patients with and without a dual disorder.

Potential topics include but are not limited to the following:

  • Painful somatic symptoms;
  • Pain and bipolar patients;
  • Pain and depressed patients;
  • Prescription substitution medications;
  • Prescription opioid for pain;
  • Pain prescription opioid use disorder;
  • Pain dual disorder patients;
  • Pain treatment in psychiatric patients;
  • Pain treatment in addiction patients;
  • Psychopathological symptoms and pain.

Prof. Dr. Icro Maremmani
Dr. Angelo G. I. Maremmani
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pain
  • psychiatry
  • addiction medicine
  • psychopathological symptoms
  • prescription pain medications (PPMs) and prescription substitution medications (PSMs)
  • prescription opioids (POs)

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

Article
The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia Syndrome
J. Clin. Med. 2020, 9(11), 3619; https://doi.org/10.3390/jcm9113619 - 10 Nov 2020
Cited by 2 | Viewed by 1198
Abstract
About half of the patients with fibromyalgia (FM) had a lifetime major depression episode and one third had a panic disorder (PD). Because the co-morbidity between bipolar disorder (BD) and PD marks a specific subtype of BD we aimed to investigate if co-morbid [...] Read more.
About half of the patients with fibromyalgia (FM) had a lifetime major depression episode and one third had a panic disorder (PD). Because the co-morbidity between bipolar disorder (BD) and PD marks a specific subtype of BD we aimed to investigate if co-morbid BD/PD (comBD/PD) occurs more frequently than the single disorder in FM patients and evaluate the clinical significance and timing of this co-morbidity. Further, we explored the role of co-morbid subthreshold BD and PD. In 118 patients with FM, lifetime threshold and sub-threshold mood disorders and PD were diagnosed with Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision (DSM-IV-TR) Clinical Interview. Demographic and clinical variables were compared in co-morbid BD/PD (comBD/PD) and not co-morbid BD/PD (nocomBD/PD) subgroups. The co-morbidity BD/PD was seen in 46.6% of FM patients and in 68.6% when patients with minor bipolar (MinBD) and sub-threshold panic were included. These rates are higher than those of the general population and BD outpatients. There were no statistically significant differences between threshold and sub-threshold comBD/PD and nocom-BD/PD subgroups in demographic and clinical parameters. In the majority of patients (78.2%), the onset of comBD/PD preceded or was contemporary with FM. These findings support the hypothesis that comBD/PD is related to the development of FM in a subgroup of patients. Full article
(This article belongs to the Special Issue Pain, Psychiatry and Addiction)
Show Figures

Figure 1

Review

Jump to: Research

Review
The Importance of a Multi-Disciplinary Approach to the Endometriotic Patients: The Relationship between Endometriosis and Psychic Vulnerability
J. Clin. Med. 2021, 10(8), 1616; https://doi.org/10.3390/jcm10081616 - 10 Apr 2021
Cited by 10 | Viewed by 2688
Abstract
Endometriosis is a chronic inflammatory condition, which is distinguished by the presence of the endometrial-like glands and stroma outside the uterine cavity. Pain and infertility are the most commonly expressed symptoms, occurring in 60% and 40% of cases, respectively. Women with endometriosis, especially [...] Read more.
Endometriosis is a chronic inflammatory condition, which is distinguished by the presence of the endometrial-like glands and stroma outside the uterine cavity. Pain and infertility are the most commonly expressed symptoms, occurring in 60% and 40% of cases, respectively. Women with endometriosis, especially those with pelvic pain, also have a greater vulnerability to several psychiatric disorders. There is, in particular, a tendency to contract affective or anxiety disorders as well as panic-agoraphobic and substance use disorders. Endometriosis with pelvic pain, infertility and psychic vulnerability usually leads to disability and a markedly lower quality of life for women of reproductive age. Thus, the burden of endometriosis is not limited to the symptoms and dysfunctions of the disease; it extends to the social, working and emotional spheres, leading to a severe impairment of global functioning. An analysis of scientific literature revealed a close relationship between specific temperamental traits, the expression of several psychiatric symptoms, chronicity of pain, risk of substance use and lower probability of a positive outcome. Endometriosis symptoms and the impact of related psychological consequences, increased vulnerability and the possible onset of psychiatric symptoms may influence coping strategies and weaken resilience, so triggering a vicious cycle leading to a marked deterioration in the quality of life. A multidisciplinary approach consisting of a medical team composed of gynecologists, psychologists, psychiatrists, experts in Dual Disorder, algologists and sexologists, would guarantee the setting of a target and taking the best decision on a personalized treatment plan. That approach would allow the prompt detection of any psychopathological symptoms and improve the endometriosis-related physical symptoms, bringing a healthier quality of life and a greater likelihood of a positive outcome. Full article
(This article belongs to the Special Issue Pain, Psychiatry and Addiction)
Show Figures

Figure 1

Back to TopTop